The Role of Aromatase Inhibitors in Male Prolactinoma

Background: dopamine agonists are the recommended treatment for male prolactinomas, but some patients may develop dopamine-agonist-resistant hyperprolactinemia, leading to persistent hypogonadism that requires treatment with testosterone. However, testosterone replacement therapy may be associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Akirov, Amit, Rudman, Yaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962537/
https://www.ncbi.nlm.nih.gov/pubmed/36835974
http://dx.doi.org/10.3390/jcm12041437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962537/
https://www.ncbi.nlm.nih.gov/pubmed/36835974
http://dx.doi.org/10.3390/jcm12041437

Ejemplares similares